The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia-Reference-Cited by-同舟云学术

The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia

Published:2018-01-15 Issue:8 Volume:110 Page:888-894
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Overman Michael J¹,Ferrarotto Renata²,Raghav Kanwal¹,George Binsah³,Qiao Wei⁴,Machado Karime K⁵,Saltz Leonard B⁶,Mazard Thibault⁷,Vauthey J N⁸,Hoff Paulo M⁹,Hobbs Brian⁴,Loyer Evelyn M¹⁰,Kopetz Scott¹

Affiliation:

1. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

2. Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

3. Division of Internal Medicine, The University of Texas Medical School, Houston, TX

4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

5. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD

6. Memorial Sloan-Kettering Cancer Center, New York, NY

7. ICM-Val d’Aurelle Cancer Center, Montpellier, France

8. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

9. Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

10. Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Funder

Roche Pharmaceuticals

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/8/888/25452130/djx288.pdf

Reference32 articles.

1. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury;Overman;J Clin Oncol.,2010

2. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases;Mehta;Eur J Surg Oncol.,2008

3. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy;Nakano;Ann Surg.,2008

4. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases;Vauthey;J Clin Oncol.,2006

5. Portal hypertension associated with oxaliplatin administration: Clinical manifestations of hepatic sinusoidal injury;Slade;Clin Colorectal Cancer.,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation;Oncology Letters;2024-07-15

2. Signaling pathways in colorectal cancer: implications for the target therapies;Molecular Biomedicine;2024-06-07

3. Major hepatectomy after preoperative liver regeneration—Experience in MDACC;Safe Major Hepatectomy After Preoperative Liver Regeneration;2024

4. Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study;BMC Cancer;2023-10-13

5. A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study;PeerJ;2023-10-13